CVS Health Corporation
CVS Health Corporation operates a vertically integrated healthcare model (pharmacy benefits, retail, clinics) with a primary political signal of $30,000 in 2024 lobbying focused on drug pricing and healthcare costs, and direct donations to 8 House members on key health and tax committees.
BusinessWhat CVS does
CVS Health is a diversified healthcare company with a vertically integrated model encompassing pharmacy benefit management (Caremark), retail pharmacy (over 9,000 stores), and primary care/health services (via HealthHUBs and MinuteClinic). Revenue lines include pharmacy services (PBM), retail/long-term care pharmacy, and health care benefits (Aetna).
12 months past · 3 months futureCVS activity timeline
Executive Branch ConflictsCVS held by Trump-administration officials
Lifetime Government AwardsCVS federal contracts by year
Smart Money · 13F HoldingsHedge funds holding CVS
Politicians Trading CVSMembers of Congress with recent CVS positions
Congressional TradesWho in Congress is trading CVS
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting CVSLive legislation impacting this stock
Political ProfileWhere CVS sits in Washington
[object Object]
STRUCTURAL: Strong committee alignment with $44,000 in donations to 8 House members on key health (Energy and Commerce) and tax (Ways and Means) committees, plus $30,000 lobbying on drug pricing. EVIDENTIARY: No recent corporate insider buys in 180-day window (get_corporate_insider_signal shows tier F, 0 buys), but two Form 4 buys in 2025 totaling ~$2.1M. Minimal federal contracts ($125k). Net: High regulatory exposure but low transactional signals.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Drug pricing and PBM regulation under House Energy and Commerce Committee jurisdictionCongress (House Committee on Energy and Commerce)"get_political_influence.donations shows donations to members of HSIF (Energy and Commerce), including ranking member Frank Pallone (D-NJ) and member Gus Bilirakis (R-FL), who chairs the Health subcomm"
Regulatory opportunities
-
Lobbying for lower healthcare costs and PBM industry education may shape favorable legislationCongress"Lobbying filings touching this ticker[0] shows $30,000 lobbying on 'issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare "
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for CVS
Live signals + predictions for CVS — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades CVS
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord